Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study-Reference-Cited by-同舟云学术

Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study

Published:2019-08 Issue:5 Volume:104 Page:1066-1073
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Alayed Yasir,Loblaw Andrew^ORCID,Chu William,Al-Hanaqta Motasem,Chiang Andrew,Jain Suneil,Chung Hans,Vesprini Danny,Morton Gerard,Ravi Ananth,Davidson Melanie,Deabreu Andrea,Mamedov Alexandre,Zhang Liying,Erler Darby,Cheung Patrick

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

2. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes;Zelefsky;Int J Radiat Oncol Biol Phys,2008

3. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials;Alayed;Radiother Oncol,2018

4. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013;Amin;Appl Health Econ Health Policy,2014

5. Stereotactic body radiotherapy for prostate cancer;Henderson;Clin Oncol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation;Frontiers in Oncology;2024-02-06

3. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review;eClinicalMedicine;2023-10

4. A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial;European Urology Open Science;2023-08

5. Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech;Cancers;2023-03-28